Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | IDO1 | P14902 | 1/20 | 0.55 |
| ▸ | NCF1 | P14598 | 6/20 | 0.47 |
| ▸ | HTR1B | P28222 | 3/20 | 0.47 |
| ▸ | HTR1D | P28221 | 1/20 | 0.47 |
| ▸ | CYBB | P04839 | 1/20 | 0.47 |
| ▸ | NOX5 | Q96PH1 | 1/20 | 0.47 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14537076 | 0.98 | IDO1 (0.58) | KMT2AALDH1A1MEN1KDM4EIDO1 | |
| SCHEMBL16305605 | 0.91 | IDO1 (0.65) | KMT2AALDH1A1MEN1KDM4EIDO1 | |
| SCHEMBL5574258 | 0.91 | KMT2A (0.49) | KMT2AALDH1A1MEN1KDM4EIDO1 | |
| SCHEMBL14511338 | 0.91 | ALDH1A1 (0.52) | KMT2AALDH1A1MEN1KDM4EIDO1 | |
| SCHEMBL14511345 | 0.91 | KDM4E (0.56) | KMT2AALDH1A1MEN1KDM4EIDO1 | |
| SCHEMBL8091013 | 0.89 | KDM4E (0.69) | KMT2AALDH1A1MEN1KDM4EHTR1B | |
| SCHEMBL16021983 | 0.89 | KDM4E (0.69) | KMT2AALDH1A1MEN1KDM4EHTR1B | |
| SCHEMBL16021969 | 0.89 | KDM4E (0.69) | KMT2AALDH1A1MEN1KDM4EHTR1B | |
| SCHEMBL16021963 | 0.89 | KDM4E (0.69) | KMT2AALDH1A1MEN1KDM4EHTR1B | |
| SCHEMBL16021973 | 0.89 | KDM4E (0.69) | KMT2AALDH1A1MEN1KDM4EHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0830354-B1 | CHEMICAL COMPLEXES | BRITISH NUCLEAR FUELS PLC (GB) | 2000-11-15 | — | — | EP | claimed |
| US-6130096-A | Chemical complexes | BRITISH NUCLEAR FUELS PLC (GB) | 2000-10-10 | — | — | US | claimed |
| US-20230248837-A1 | Technology for Modulating Targeting Chimeras Induced by Cell-Penetrating Peptide and Application Thereof | LIU, MIAO (CN) | 2023-08-10 | — | — | US | disclosed |
| US-9997272-B2 | Modular supramolecular approach for co-crystallization of donors and acceptors into ordered networks | NORTHWESTERN UNIVERSITY (US) | 2018-06-12 | — | — | US | disclosed |
| US-9997272-B2 | Modular supramolecular approach for co-crystallization of donors and acceptors into ordered networks | NORTHWESTERN UNIVERSITY (US) | 2018-06-12 | — | — | US | disclosed |
| US-9449731-B2 | Modular supramolecular approach for co-crystallization of donors and acceptors into ordered networks | NORTHWESTERN UNIVERSITY (US) | 2016-09-20 | — | — | US | disclosed |
| US-9449731-B2 | Modular supramolecular approach for co-crystallization of donors and acceptors into ordered networks | NORTHWESTERN UNIVERSITY (US) | 2016-09-20 | — | — | US | disclosed |
| US-20070117964-A1 | Noncovalent functionalization of nanotubes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-05-24 | — | — | US | disclosed |
| US-20070117964-A1 | Noncovalent functionalization of nanotubes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-05-24 | — | — | US | disclosed |
| US-20070117964-A1 | Noncovalent functionalization of nanotubes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-05-24 | — | — | US | disclosed |
| US-7220818-B2 | Noncovalent functionalization of nanotubes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-05-22 | — | — | US | disclosed |
| US-7220818-B2 | Noncovalent functionalization of nanotubes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-05-22 | — | — | US | disclosed |
| US-7220818-B2 | Noncovalent functionalization of nanotubes | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-05-22 | — | — | US | disclosed |
| US-20050043503-A1 | With poly{(5-alkoxy-m-phenylenevinylene)-co-[(2,5-dioctyloxy-p-phenylene)vinylene]} or other derivatives; high strength, increased solubility, electroconductivity with maintained photoluminescence and electroluminescence | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2005-02-24 | — | — | US | disclosed |
| EP-0830354-B1 | CHEMICAL COMPLEXES | BRITISH NUCLEAR FUELS PLC (GB) | 2000-11-15 | — | — | EP | disclosed |
| US-6130096-A | Chemical complexes | BRITISH NUCLEAR FUELS PLC (GB) | 2000-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248837-A1 | Technology for Modulating Targeting Chimeras Induced by Cell-Penetrating Peptide and Application Thereof | VIP, GHITM, MYCBP | KMT2A 3720/4885ALDH1A1 4851/4885MEN1 1339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.